Filter News
Area of Research
News Topics
- (-) Isotopes (2)
- (-) Materials (5)
- (-) Microscopy (2)
- (-) Neutron Science (1)
- (-) Physics (2)
- 3-D Printing/Advanced Manufacturing (3)
- Artificial Intelligence (2)
- Big Data (1)
- Bioenergy (6)
- Biology (11)
- Biomedical (5)
- Biotechnology (3)
- Buildings (1)
- Chemical Sciences (4)
- Clean Water (2)
- Climate Change (8)
- Composites (1)
- Computer Science (7)
- Coronavirus (8)
- Decarbonization (2)
- Energy Storage (2)
- Environment (16)
- High-Performance Computing (8)
- Hydropower (2)
- Machine Learning (3)
- Materials Science (3)
- Mathematics (2)
- Mercury (1)
- Molten Salt (1)
- Nanotechnology (3)
- Net Zero (1)
- Partnerships (2)
- Simulation (7)
- Summit (4)
- Sustainable Energy (3)
- Transportation (1)
Media Contacts
Four scientists affiliated with ORNL were named Battelle Distinguished Inventors during the lab’s annual Innovation Awards on Dec. 1 in recognition of being granted 14 or more United States patents.
Madhavi Martin brings a physicist’s tools and perspective to biological and environmental research at the Department of Energy’s Oak Ridge National Laboratory, supporting advances in bioenergy, soil carbon storage and environmental monitoring, and even helping solve a murder mystery.
Scientist-inventors from ORNL will present seven new technologies during the Technology Innovation Showcase on Friday, July 14, from 8 a.m.–4 p.m. at the Joint Institute for Computational Sciences on ORNL’s campus.
Three scientists from the Department of Energy’s Oak Ridge National Laboratory have been elected fellows of the American Association for the Advancement of Science, or AAAS.
Six scientists at the Department of Energy’s Oak Ridge National Laboratory were named Battelle Distinguished Inventors, in recognition of obtaining 14 or more patents during their careers at the lab.
The annual Director's Awards recognized four individuals and teams including awards for leadership in quantum simulation development and application on high-performance computing platforms, and revolutionary advancements in the area of microbial
Experiments led by researchers at ORNL have determined that several hepatitis C drugs can inhibit the SARS-CoV-2 main protease, a crucial protein enzyme that enables the novel coronavirus to reproduce.